Cargando…

Investigating the pertussis resurgence in England and Wales, and options for future control

BACKGROUND: In 2012 England and Wales experienced a resurgence of pertussis and an increase in infant deaths. This occurred 8 years after acellular pertussis (aP) vaccine replaced whole cell (wP) primary vaccine despite continued high coverage for the primary series and pre-school aP booster. We dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoon Hong, Campbell, Helen, Amirthalingam, Gayatri, van Hoek, Albert Jan, Miller, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007864/
https://www.ncbi.nlm.nih.gov/pubmed/27580649
http://dx.doi.org/10.1186/s12916-016-0665-8
_version_ 1782451283104366592
author Choi, Yoon Hong
Campbell, Helen
Amirthalingam, Gayatri
van Hoek, Albert Jan
Miller, Elizabeth
author_facet Choi, Yoon Hong
Campbell, Helen
Amirthalingam, Gayatri
van Hoek, Albert Jan
Miller, Elizabeth
author_sort Choi, Yoon Hong
collection PubMed
description BACKGROUND: In 2012 England and Wales experienced a resurgence of pertussis and an increase in infant deaths. This occurred 8 years after acellular pertussis (aP) vaccine replaced whole cell (wP) primary vaccine despite continued high coverage for the primary series and pre-school aP booster. We developed a mathematical model to describe pertussis transmission dynamics in England and Wales since the 1950s and used it to investigate the cause of the resurgence and the potential impact of additional vaccination strategies. METHODS: An age-structured, compartmental, deterministic model of the pertussis transmission dynamics was fitted to 60 continuous years of age-stratified pertussis notification data in England and Wales. The model incorporated vaccine-induced and natural immunity and differentiated between vaccine-induced protection against clinical disease and infection. RESULTS: The degree of protection of wP vaccine against infection was estimated to be higher than that of aP vaccine. Furthermore, the duration of protection for natural and wP-induced immunity was likely to be at least 15 years, but for aP vaccine it could be as low as 5 years. Model results indicated that the likely cause of the resurgence was the replacement of wP by less efficacious aP vaccine and that an elevated level of pertussis would continue. The collapse in wP vaccine coverage in the 1970s and resultant outbreaks in the late 1970s and early 1980s could not explain the resurgence. Addition of an adolescent or toddler booster was predicted to have little impact on the disease in infants. CONCLUSIONS: Our findings support the recent recommendation by the World Health Organisation that countries currently using wP vaccine for primary immunisation should not change to aP vaccine unless additional strategies to control infant disease such as maternal immunisation can be assured. Improved pertussis vaccines that provide better protection against infection are needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0665-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5007864
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50078642016-09-02 Investigating the pertussis resurgence in England and Wales, and options for future control Choi, Yoon Hong Campbell, Helen Amirthalingam, Gayatri van Hoek, Albert Jan Miller, Elizabeth BMC Med Research Article BACKGROUND: In 2012 England and Wales experienced a resurgence of pertussis and an increase in infant deaths. This occurred 8 years after acellular pertussis (aP) vaccine replaced whole cell (wP) primary vaccine despite continued high coverage for the primary series and pre-school aP booster. We developed a mathematical model to describe pertussis transmission dynamics in England and Wales since the 1950s and used it to investigate the cause of the resurgence and the potential impact of additional vaccination strategies. METHODS: An age-structured, compartmental, deterministic model of the pertussis transmission dynamics was fitted to 60 continuous years of age-stratified pertussis notification data in England and Wales. The model incorporated vaccine-induced and natural immunity and differentiated between vaccine-induced protection against clinical disease and infection. RESULTS: The degree of protection of wP vaccine against infection was estimated to be higher than that of aP vaccine. Furthermore, the duration of protection for natural and wP-induced immunity was likely to be at least 15 years, but for aP vaccine it could be as low as 5 years. Model results indicated that the likely cause of the resurgence was the replacement of wP by less efficacious aP vaccine and that an elevated level of pertussis would continue. The collapse in wP vaccine coverage in the 1970s and resultant outbreaks in the late 1970s and early 1980s could not explain the resurgence. Addition of an adolescent or toddler booster was predicted to have little impact on the disease in infants. CONCLUSIONS: Our findings support the recent recommendation by the World Health Organisation that countries currently using wP vaccine for primary immunisation should not change to aP vaccine unless additional strategies to control infant disease such as maternal immunisation can be assured. Improved pertussis vaccines that provide better protection against infection are needed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0665-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-01 /pmc/articles/PMC5007864/ /pubmed/27580649 http://dx.doi.org/10.1186/s12916-016-0665-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Choi, Yoon Hong
Campbell, Helen
Amirthalingam, Gayatri
van Hoek, Albert Jan
Miller, Elizabeth
Investigating the pertussis resurgence in England and Wales, and options for future control
title Investigating the pertussis resurgence in England and Wales, and options for future control
title_full Investigating the pertussis resurgence in England and Wales, and options for future control
title_fullStr Investigating the pertussis resurgence in England and Wales, and options for future control
title_full_unstemmed Investigating the pertussis resurgence in England and Wales, and options for future control
title_short Investigating the pertussis resurgence in England and Wales, and options for future control
title_sort investigating the pertussis resurgence in england and wales, and options for future control
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007864/
https://www.ncbi.nlm.nih.gov/pubmed/27580649
http://dx.doi.org/10.1186/s12916-016-0665-8
work_keys_str_mv AT choiyoonhong investigatingthepertussisresurgenceinenglandandwalesandoptionsforfuturecontrol
AT campbellhelen investigatingthepertussisresurgenceinenglandandwalesandoptionsforfuturecontrol
AT amirthalingamgayatri investigatingthepertussisresurgenceinenglandandwalesandoptionsforfuturecontrol
AT vanhoekalbertjan investigatingthepertussisresurgenceinenglandandwalesandoptionsforfuturecontrol
AT millerelizabeth investigatingthepertussisresurgenceinenglandandwalesandoptionsforfuturecontrol